Daptacel Lawsuit
If the Daptacel® DTaP vaccine caused your child to develop a serious Shoulder Injury Related to Vaccine Administration (SIRVA), you could receive up to $250,000 in compensation.
Overview
Daptacel® is a DTaP vaccine that helps protect children against infections with tetanus, diphtheria, and pertussis (whooping cough).
How is Daptacel Given?
Daptacel is given in a series of 5 separate shots to infants and children between the ages of 6 weeks and 6 years old. A single 0.5-mL intramuscular injection is administered at the ages of 2 months, 4 months, 6 months, 15-20 months, and at 4-6 years of age. The vaccine can be injected into the thigh muscle of young infants or toddlers, or the deltoid muscle of the upper arm in older children.
Can Daptacel Cause SIRVA?
Daptacel vaccines that are injected too high or too deep into the upper arm can potentially cause a devastating inflammatory shoulder injury known as Shoulder Injury Related to Vaccine Administration (SIRVA).
What is SIRVA?
SIRVA is believed to occur when the vaccine needle accidentally damages the bursa or other sensitive tissues in the shoulder, triggering an inflammatory reaction from the immune system.
What is the Risk?
A person who develops SIRVA experiences severe pain that persists much longer than the normal pain after a vaccine. The shoulder pain is often accompanied by muscle weakness and limited flexibility. In severe cases, people with SIRVA may suffer a lifelong disability.
Symptoms of SIRVA After Daptacel Vaccine
- Arm pain
- Shoulder pain
- Intense, stabbing pain
- Shoulder dysfunction
- Limited range of motion
- Lack of flexibility
- Inflammation
Daptacel Lawsuits
Daptacel DTaP vaccines rarely cause SIRVA because this condition is uncommon in children, but it can occur. If your child received Daptacel and developed SIRVA, you may be eligible for up to $250,000 from the Vaccine Injury Compensation Program (VICP).
What is the VICP?
Congress established the Vaccine Injury Compensation Program (VICP) in the 1980s by placing a $0.75 tax on the sale of every vaccine. The money is used to provide financial payments to people who develop vaccine injuries, while also prohibiting everyone from filing lawsuits against pharmaceutical companies that make vaccines.
Over $70 Million Paid in SIRVA Lawsuits Since 2011
Since 2011, around 500 people who developed SIRVA from vaccines have been paid about $70 million from the VICP. The average payout for a SIRVA lawsuit settlement is around $140,000, but the maximum payout is $250,000 for pain, medical costs, and disability.
SIRVA Lawsuit Settlements